These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 14981974

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Lymphocyte labile iron pool, plasma iron, transferrin saturation and ferritin levels in colon cancer patients.
    Gackowski D, Kruszewsk M, Banaszkiewicz Z, Jawien A, Olinski R.
    Acta Biochim Pol; 2002; 49(1):269-72. PubMed ID: 12136950
    [Abstract] [Full Text] [Related]

  • 23. Proteinuria and hemoglobin levels in patients with primary glomerular disease.
    Mähr N, Neyer U, Prischl F, Kramar R, Mayer G, Kronenberg F, Lhotta K.
    Am J Kidney Dis; 2005 Sep; 46(3):424-31. PubMed ID: 16129203
    [Abstract] [Full Text] [Related]

  • 24. Iron prophylaxis during pregnancy -- how much iron is needed? A randomized dose- response study of 20-80 mg ferrous iron daily in pregnant women.
    Milman N, Bergholt T, Eriksen L, Byg KE, Graudal N, Pedersen P, Hertz J.
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):238-47. PubMed ID: 15715531
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population.
    Stewart R, Hirani V.
    Psychosom Med; 2012 Mar; 74(2):208-13. PubMed ID: 22286844
    [Abstract] [Full Text] [Related]

  • 27. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
    Shinzato T, Abe K, Furusu A, Harada T, Shinzato K, Miyazaki M, Kohno S.
    Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
    [Abstract] [Full Text] [Related]

  • 28. Iron homeostasis in relapsing steroid-sensitive nephrotic syndrome of childhood.
    Kemper MJ, Bello AB, Altrogge H, Timmermann K, Ludwig K, Müller-Wiefel DE.
    Clin Nephrol; 1999 Jul; 52(1):25-9. PubMed ID: 10442492
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Factors accounting for high ferritin levels in obesity.
    Lecube A, Hernández C, Pelegrí D, Simó R.
    Int J Obes (Lond); 2008 Nov; 32(11):1665-9. PubMed ID: 18779821
    [Abstract] [Full Text] [Related]

  • 31. [The comparison of diagnostic usefulness of transferrin determination by immunological and chemical method in iron deficiency anemia].
    Krawiec A, Cylwik B, Chrostek L, Szmitkowski M.
    Pol Merkur Lekarski; 2007 Mar; 22(129):173-6. PubMed ID: 17682669
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease.
    Marković M, Majkić-Singh N, Subota V.
    Scand J Clin Lab Invest; 2005 Mar; 65(7):571-6. PubMed ID: 16271988
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Might patients benefit from oral iron therapy following operative treatment of breast carcinoma?
    Cutress RI, Gupta R, Parakh A, Rutter D, Spencer L, Royle GT.
    Eur J Surg Oncol; 2001 Nov; 27(7):621-5. PubMed ID: 11669588
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.